# AbCellera Biologics Inc.: Form 8-K, filed Sep 10, 2025

- Company: [AbCellera Biologics Inc.](/companies/abcl.md) (CIK 1703057)
- Form: 8-K
- Filed: 2025-09-10
- Accepted by EDGAR: Sep 10, 2025, 12:23 ET
- Period: 2025-09-10
- Accession: 0001703057-25-000018
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1703057/000170305725000018/abcl-20250910.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1703057/000170305725000018/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1703057/000170305725000018/abcl-20250910.htm

Filed Sep 10, 2025.
Source: SEC EDGAR, the filing index for accession 0001703057-25-000018. Last ingested by Listed: Nov 15, 2026, 01:06 ET. No prices; not investment advice.
